{"schema_version":"secwatch.filing_event.v1","accession":"0001628280-22-012714","form_type":"8-K","ticker":"TOI","cik":"0001799191","company_name":"Oncology Institute, Inc.","filed_at":"2022-05-05T23:59:59+00:00","discovered_at":"2026-05-14T18:04:02.357490+00:00","generated_at":"2026-06-25T23:55:54.577578+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"CFO Scott Dalgleish departs April 29; enters consulting pact through May 31, 2022","bullets":["CFO Scott Dalgleish's last employment date was April 29, 2022; consulting agreement effective April 30 to May 31, 2022.","Consulting agreement allows continued vesting of up to 15,183 stock options; exercise period extended to Dec 31, 2022.","Separation and consulting terms described as ordinary course transition; no replacement named."],"urls":{"canonical":"https://secwatch.observer/filing/0001628280-22-012714","json":"https://secwatch.observer/filing/0001628280-22-012714.json","markdown":"https://secwatch.observer/filing/0001628280-22-012714.md","text":"https://secwatch.observer/filing/0001628280-22-012714.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1799191/000162828022012714/0001628280-22-012714-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1799191/000162828022012714/toi-20220429.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-25T23:55:54.577578+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"892eb0ae6a","claim":"Scott Dalgleish departed as Chief Financial Officer at Oncology Institute, Inc..","evidence_excerpt":"Mr. Dalgleish’s last date of employment with the Company was April 29, 2022.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1799191/000162828022012714/0001628280-22-012714-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"departed"},{"label":"Role","value":"Chief Financial Officer"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}